TALPHERA INC (TLPH) Stock Fundamental Analysis
USA - NASDAQ:TLPH - US00444T2096 - Common Stock
1.32 USD
+0.07 (+5.6%)
1.3015 USD
-0.02 (-1.4%)
Taking everything into account, TLPH scores 3 out of 10 in our fundamental rating. TLPH was compared to 192 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of TLPH while its profitability can be described as average. TLPH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
TLPH had negative earnings in the past year.
In the past year TLPH had a positive cash flow from operations.
In the past 5 years TLPH reported 4 times negative net income.
TLPH had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of TLPH (1.36%) is better than 82.29% of its industry peers.
Looking at the Return On Equity, with a value of 2.52%, TLPH belongs to the top of the industry, outperforming 83.85% of the companies in the same industry.
With an excellent Return On Invested Capital value of 1.96%, TLPH belongs to the best of the industry, outperforming 80.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.52% | ||
| ROIC | 1.96% |
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TLPH's Profit Margin of 14.91% is amongst the best of the industry. TLPH outperforms 87.50% of its industry peers.
The Operating Margin of TLPH (24.41%) is better than 90.63% of its industry peers.
With an excellent Gross Margin value of 253.62%, TLPH belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.41% | ||
| PM (TTM) | 14.91% | ||
| GM | 253.62% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TLPH is destroying value.
TLPH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TLPH has more shares outstanding
TLPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
TLPH has an Altman-Z score of 0.31. This is a bad value and indicates that TLPH is not financially healthy and even has some risk of bankruptcy.
TLPH's Altman-Z score of 0.31 is in line compared to the rest of the industry. TLPH outperforms 52.60% of its industry peers.
TLPH has a debt to FCF ratio of 3.91. This is a good value and a sign of high solvency as TLPH would need 3.91 years to pay back of all of its debts.
TLPH's Debt to FCF ratio of 3.91 is amongst the best of the industry. TLPH outperforms 85.42% of its industry peers.
TLPH has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, TLPH perfoms like the industry average, outperforming 41.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 3.91 | ||
| Altman-Z | 0.31 |
ROIC/WACC0.22
WACC8.75%
2.3 Liquidity
TLPH has a Current Ratio of 0.54. This is a bad value and indicates that TLPH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of TLPH (0.54) is worse than 92.19% of its industry peers.
A Quick Ratio of 0.53 indicates that TLPH may have some problems paying its short term obligations.
TLPH has a Quick ratio of 0.53. This is amonst the worse of the industry: TLPH underperforms 91.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.54 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 44.93% over the past year.
The Revenue for TLPH has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to grow by 22.69% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2Y-4.88%
EPS Next 3Y6.27%
EPS Next 5Y22.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
TLPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TLPH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TLPH is valued cheaper than 98.44% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TLPH is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.06 | ||
| EV/EBITDA | 2.72 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.88%
EPS Next 3Y6.27%
5. Dividend
5.1 Amount
TLPH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.32
+0.07 (+5.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners20.74%
Inst Owner ChangeN/A
Ins Owners9.03%
Ins Owner Change0.28%
Market Cap60.18M
Revenue(TTM)1.38B
Net Income(TTM)206.45M
Analysts82.22
Price Target4.25 (221.97%)
Short Float %5.53%
Short Ratio3.7
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend23.88
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.47%
Min EPS beat(2)1.96%
Max EPS beat(2)22.97%
EPS beat(4)4
Avg EPS beat(4)29.17%
Min EPS beat(4)1.96%
Max EPS beat(4)57.11%
EPS beat(8)7
Avg EPS beat(8)24.45%
EPS beat(12)10
Avg EPS beat(12)20.71%
EPS beat(16)14
Avg EPS beat(16)19.45%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.04 | ||
| P/FCF | 0.06 | ||
| P/OCF | 0.02 | ||
| P/B | 0.01 | ||
| P/tB | 0.01 | ||
| EV/EBITDA | 2.72 |
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)21.59
FCFY1635.82%
OCF(TTM)53.14
OCFY4025.86%
SpS30.37
BVpS179.96
TBVpS174.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 2.52% | ||
| ROCE | 2.49% | ||
| ROIC | 1.96% | ||
| ROICexc | 1.97% | ||
| ROICexgc | 2% | ||
| OM | 24.41% | ||
| PM (TTM) | 14.91% | ||
| GM | 253.62% | ||
| FCFM | 71.1% |
ROA(3y)-24.13%
ROA(5y)-35.67%
ROE(3y)-32.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 3.91 | ||
| Debt/EBITDA | 2.28 | ||
| Cap/Depr | 130.74% | ||
| Cap/Sales | 103.88% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 168.48% | ||
| Profit Quality | 476.84% | ||
| Current Ratio | 0.54 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 0.31 |
F-Score6
WACC8.75%
ROIC/WACC0.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y0%
EPS Next 2Y-4.88%
EPS Next 3Y6.27%
EPS Next 5Y22.69%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5256.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12884.8%
OCF growth 3YN/A
OCF growth 5YN/A
TALPHERA INC / TLPH FAQ
What is the fundamental rating for TLPH stock?
ChartMill assigns a fundamental rating of 3 / 10 to TLPH.
Can you provide the valuation status for TALPHERA INC?
ChartMill assigns a valuation rating of 2 / 10 to TALPHERA INC (TLPH). This can be considered as Overvalued.
How profitable is TALPHERA INC (TLPH) stock?
TALPHERA INC (TLPH) has a profitability rating of 5 / 10.
Can you provide the financial health for TLPH stock?
The financial health rating of TALPHERA INC (TLPH) is 3 / 10.
What is the expected EPS growth for TALPHERA INC (TLPH) stock?
The Earnings per Share (EPS) of TALPHERA INC (TLPH) is expected to decline by 0% in the next year.